Firms

moorecapital.com

Moore Strategic Ventures is the privately held investment company of Louis Bacon.

Founded

—

Type

Venture capital

Team

No team members on record yet.

Co-investing

Andreessen Horowitz

• Maze Therapeutics$115M · 2024
• Orbital Therapeutics$270M · 2023-04-26
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20

ARCH Venture Partners

• Elephas$55M · 2024-01-23
• Elephas Biosciences$55M · 2024-01-23
• Maze Therapeutics$115M · 2024
• Myeloid Therapeutics$73M · 2023-05-18
• Orbital Therapeutics$270M · 2023-04-26

Baillie Gifford

• Wayve$200M · 2022-01-18
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20

Founders Fund

• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021

137 Ventures

• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021-05-20
• Workrise$300M · 2021

SHOW MORE

Investments

$75M2022-12-15	Synchron	ARCH Venture Partners, Bezos Expeditions, Khosla Ventures, Gates Frontier, Reliance Digital Health, Greenoaks, Alumni Ventures, Moore Strategic Ventures, Project X, Neuro Technology Investors, METIS Innovative, Forepont Capital Partners, ID8 Investments, Shanda Group, University of Melbourne
$16M2026-02-23	XFlow	General Catalyst, PayPal Ventures, Moore Strategic Ventures, Stripe, Lightspeed, Square Peg Capital
$55M2024-01-23	Elephas	ARCH Venture Partners, Tao Capital Partners, Northpond Ventures, Sands Capital, Moore Strategic Ventures
$55M2024-01-23	Elephas Biosciences	ARCH Venture Partners, Northpond Ventures, SV Health Investors, Sands Capital, Moore Strategic Ventures, AF Ventures
$115M2024	Maze Therapeutics	ARCH Venture Partners, Casdin Capital, Andreessen Horowitz, Logos Capital, GV, General Catalyst, Moore Strategic Ventures
$73M2023-05-18	Myeloid Therapeutics	ARCH Venture Partners, 8VC, Alexandria Venture Investments, Moore Strategic Ventures, Primary Venture Partners, Newpath Partners
$270M2023-04-26	Orbital Therapeutics	ARCH Venture Partners, Casdin Capital, Alexandria Venture Investments, Andreessen Horowitz, Moore Strategic Ventures, Newpath Partners, Vineeta Agarwala
$200M2022-01-18	Wayve	Eclipse, Compound, D1 Capital Partners, M12, Lince Capital, Baillie Gifford, Moore Strategic Ventures, Balderton Capital
$355M2022-01-14	Bolt	BlackRock, Schonfeld Strategic Advisors, H.I.G. Growth Partners, Invus Opportunities, CreditEase, Activant Capital, Moore Strategic Ventures, CE Innovation Capital, Digital Horizon
$200M2021-07-13	Prime Medicine, Inc.	ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Casdin Capital, Cormorant Asset Management, Moore Strategic Ventures, PSP Investments, Redmile Group, Samsara BioCapital, T. Rowe Price Associates

SHOW MORE